Unjustified discontinuation of bee venom immunotherapy;Ungerechtfertigte abbrüche der bienengift-hyposensibilisierung

Allergo Journal

Volumn 11, Issue 2, 2002, Pages 104-108

  Ruëff, Franziska ^a   Przybilla, Bernhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Compliance; Hymenoptera venom allergy; Treatment stop; Venom immunotherapy

Indexed keywords

BEE VENOM;

ADULT; AGED; ALLERGY; ARTICLE; FEMALE; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

EID: 0036221868     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03360952     Document Type: Article

References (25)

1. WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases
2. Immunotherapy with Hymenoptera venoms
3. Determinants of patient compliance with allergen immunotherapy
4. Dose dependence of Hymenoptera venom immunotherapy
5. Discontinuing venom immunotherapy: Outcome after five years
6. Compliance with allergen immunotherapy
7. Constitutionally raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings
8. Honeybee venom allergy: Results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients
9. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety
10. Position paper: Immunotherapy with Hymenoptera venoms
11. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis
12. Hyposensibilisierungsbehandlung der Hymenopterengiftallergie: Aspekte der indikationsstellung und dosierung
13. Hymenoptera venom allergy
14. Schnellhyposensibilisierung mit hymenopterengiften. Verträiglichkeit und therapieerfolg
15. Insektengiftallergie. Gemeinsame leitlinie von DGAI und ÄDA
16. Hymenopterengiftallergie
17. Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom iramunotherapy
18. Efficacy and safety of honeybee venom immunotherapy with an aqueous and an aluminium hydroxyde adsorbed depot extract
19. Diagnose und therapie der bienen- und wespengiftallergie
20. The sting challenge test in Hymenoptera venom allergy
21. Nebenwirkungen der schnellhyposensibilisierung mit Hymenopterengift
22. Failure of conventional Hymenoptera venom immunotherapy: Most patients are protected by increase of the venom dose
23. Development of a new, more sensitive immunoassy for human tryptase: Use in systemic anaphylaxis
24. Patienten-compliance bei der hyposensibilisierung
25. Compliance with an allergen immunotherapy regime